Health ❯ Neurodegenerative Diseases
Parkinson's Disease Research Treatment Risk Factors Diagnosis Gender Differences Inflammation Brain Cell Death Biomarkers Caregiving Genetics Amyloids Treatment Options RNA Interference SuperAgers Treatment Strategies Research Findings Posterior Cortical Atrophy Transmission of Alzheimer's Disease Early-Onset Alzheimer's Transmissible Dementia APOE4 Lipids APOE Protein Aggregates Gene Length Donanemab Drug Development Research Institutions Vascular Contributions Gut-Brain Axis Preventative Strategies Social Behavior Immune System Cellular Stress Pathology Genetic Factors Symptoms Impact on Quality of Life Public Health Impact of Microplastics Research Techniques Cell Death Mechanisms Toxins Brain Damage Symptoms Management Genetic Risk Factors Therapeutics Brain Regions Therapies Genetic Mutations Protein Aggregation Amyloid-Beta Aggregates Environmental Factors Physical Activity Drug Repurposing Amyloid Precursor Protein Brain Function Causes Viral Infections Pathways to Alzheimer's Brain Cell Loss
Targeting acetylated tau, the candidate has entered an FDA-cleared first-in-human trial with Sanofi set to lead later development.
